Estimated Life-Years Saved in Women With HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States
Value in Health - United Kingdom
doi 10.1016/j.jval.2015.06.003
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2015
Authors
Publisher
Elsevier BV